Victory Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.22M | Buy |
|
|||||
|
2025
Q2 | $7.31M | Sell |
|
|||||
|
2025
Q1 | $13.1M | Buy |
|
|||||
|
2024
Q4 | $6.18M | Buy |
|
|||||
|
2024
Q3 | $5.8M | Buy |
|
|||||
|
2024
Q2 | $4.27M | Sell |
|
|||||
|
2024
Q1 | $4.44M | Buy |
|
|||||
|
2023
Q4 | $4.33M | Sell |
|
|||||
|
2023
Q3 | $3.64M | Buy |
|
|||||
|
2023
Q2 | $3.95M | Buy |
|
|||||
|
2023
Q1 | $4.79M | Sell |
|
|||||
|
2022
Q4 | $5.45M | Sell |
|
|||||
|
2022
Q3 | $4.7M | Buy |
|
|||||
|
2022
Q2 | $2.56M | Sell |
|
|||||
|
2022
Q1 | $3.04M | Buy |
|
|||||
|
2021
Q4 | $739K | Sell |
|
|||||
|
2021
Q3 | $775K | Sell |
|
|||||
|
2021
Q2 | $1.11M | Sell |
|
|||||
|
2021
Q1 | $933K | Buy |
|
|||||
|
2020
Q4 | $477K | Buy |
|
|||||
|
2020
Q3 | $333K | Buy |
|
|||||
|
2020
Q2 | $409K | Sell |
|
|||||
|
2020
Q1 | $622K | Buy |
|
|||||
|
2019
Q4 | $250K | Buy |
|
|||||
|
2019
Q3 | $227K | Buy |
|